MDWD
MediWound Ltd.·Healthcare
14.33
14.089%(−2.35)
Close PriceLast Updated: — ET
52W L: $14.1452W H: $22.50
MDWD NEWS
seekingalpha.com
13h ago
MediWound Ltd. (MDWD) Q1 2026 Earnings Call Transcript
MediWound Ltd. (MDWD) Q1 2026 Earnings Call Transcript
marketbeat.com
16h ago
MediWound Q1 Earnings Call Highlights
MediWound NASDAQ: MDWD reported a wider first-quarter loss and lower revenue compared with the prior-year period, while management reaffirmed its 2026 revenue outlook and said it continued to advance its EscharEx and NexoBrid programs.
zacks.com
17h ago
MediWound (MDWD) Reports Q1 Loss, Misses Revenue Estimates
MediWound (MDWD) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.65. This compares to a loss of $0.07 per share a year ago.
globenewswire.com
20h ago
MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update
EscharEx ® Phase III VALUE trial advancing; interim assessment and enrollment completion expected by the end of the first quarter of 2027 First quarter revenue of $1.5 million; full-year 2026 revenue guidance reaffirmed at $24-26 million Conference Call Today, May 27, 2026, at 8:30 a.m. Eastern Time YAVNE, Israel, May 27, 2026 (GLOBE NEWSWIRE) -- MediWound Ltd.
globenewswire.com
May 7
MediWound to Report First Quarter 2026 Financial Results
MediWound to Report First Quarter 2026 Financial Results Conference Call and Webcast Scheduled for Wednesday, May 27 th at 8:30 a.m. Eastern Time YAVNE, Israel, May 7, 2026 -- MediWound Ltd.
defenseworld.net
Apr 15
Head-To-Head Review: Surrozen (NASDAQ:SRZN) & MediWound (NASDAQ:MDWD)
Surrozen (NASDAQ: SRZN - Get Free Report) and MediWound (NASDAQ: MDWD - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, earnings, risk, dividends, valuation, analyst recommendations and profitability. Institutional and Insider Ownership 66.6% of Surrozen shares are
